Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5201
State Street SPDR Portfolio Europe ETF
SPEU
$703M
| $3.13K | ﹤0.01% |
+57
| New | +$3.1K |
2026 Q2
0 quarters
|
|
5202
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
| $3.1K | ﹤0.01% |
+35
| New | +$3.04K |
2026 Q2
0 quarters
|
|
5203
CALL
Janux Therapeutics
JANX
$1.09B
| $3.07K | ﹤0.01% |
+200
| New | +$2.9K |
2026 Q2
0 quarters
|
|
|
5204
PUT
Janux Therapeutics
JANX
$1.09B
| $3.07K | ﹤0.01% |
+200
| New | +$2.9K |
2026 Q2
0 quarters
|
|
5205
Studio City International Holdings
MSC
$206M
| $2.98K | ﹤0.01% |
1,629
| – | – |
2018 Q4
30 quarters
|
|
5206
PepGen
PEPG
$170M
| $2.93K | ﹤0.01% |
1,627
-879
| -35% | -$1.43K |
2022 Q2
16 quarters
|
|
5207
Coffee Holding Co
JVA
$28.8M
| $2.93K | ﹤0.01% |
876
+865
| +7,864% | +$3.66K |
2025 Q3
3 quarters
|
|
5208
InflaRx
IFRX
$239M
| $2.91K | ﹤0.01% |
1,301
-1
| -0.1% | -$2 |
2022 Q1
17 quarters
|
|
5209
Goldman Sachs BDC
GSBD
$994M
| $2.88K | ﹤0.01% |
304
| – | – |
2023 Q3
11 quarters
|
|
5210
Phunware
PHUN
$36.2M
| $2.78K | ﹤0.01% |
1,354
+1,351
| +45,033% | +$2.73K |
2025 Q3
3 quarters
|
|
5211
American Strategic Investment Co
NYC
$19.2M
| $2.67K | ﹤0.01% |
+277
| New | +$2.36K |
2026 Q2
0 quarters
|
|
5212
Greenlane Holdings
GNLN
$861K
| $2.63K | ﹤0.01% |
+1,086
| New | +$3.86K |
2026 Q2
0 quarters
|
|
5213
Intelligent Protection Management Corp
IPM
$21.4M
| $2.6K | ﹤0.01% |
1,497
+1,496
| +149,600% | +$2.72K |
2025 Q2
4 quarters
|
|
5214
Central Puerto
CEPU
$1.55B
| $2.54K | ﹤0.01% |
171
-86
| -33% | -$1.3K |
2026 Q1
1 quarter
|
|
5215
Firefly Neuroscience
AIFF
$15.4M
| $2.53K | ﹤0.01% |
2,091
-26,572
| -93% | -$46.3K |
2026 Q1
1 quarter
|
|
5216
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.62B
| $2.52K | ﹤0.01% |
+59
| New | +$2.51K |
2026 Q2
0 quarters
|
|
5217
Mynd.ai
MYND
$14.7M
| $2.49K | ﹤0.01% |
6,504
+3,759
| +137% | +$1.35K |
2025 Q3
3 quarters
|
|
5218
CALL
CID HoldCo Inc Warrants
DAICW
$79.9K
| $2.48K | ﹤0.01% |
200,001
| – | – |
2025 Q2
4 quarters
|
|
5219
CVR Partners
UAN
$1.25B
| $2.45K | ﹤0.01% |
22
-2,027
| -99% | -$249K |
2025 Q2
4 quarters
|
|
5220
Carlyle Secured Lending
CGBD
$742M
| $2.4K | ﹤0.01% |
+228
| New | +$2.54K |
2026 Q2
0 quarters
|
|
|
CURX
5221
Curanex Pharmaceuticals
CURX
$9.7M
| $2.38K | ﹤0.01% |
448
-519
| -54% | -$3.78K |
2026 Q1
1 quarter
|
|
|
EROC
5222
ERock Inc
EROC
$432M
| $2.32K | ﹤0.01% |
+160
| New | +$2.55K |
2026 Q2
0 quarters
|
|
5223
CervoMed
CRVO
$23.4M
| $2.06K | ﹤0.01% |
+664
| New | +$2.34K |
2026 Q2
0 quarters
|
|
5224
HUTCHMED
HCM
$2.27B
| $2.06K | ﹤0.01% |
191
| – | – |
2018 Q4
30 quarters
|
|
5225
Rani Therapeutics
RANI
$64.2M
| $2.01K | ﹤0.01% |
2,643
-83
| -3% | -$74 |
2025 Q4
2 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.